Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Einar Gude

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Health and Quality of Life Outcomes|August 19, 2020
High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trialKatrine Rolid, Arne K Andreassen, Marianne Yardley, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2016
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trialLars Gullestad, Hans Eiskjaer, Finn Gustafsson, et al.
Heart (British Cardiac Society)|October 28, 2024
Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertensionHåvard Ravnestad, Klaus Murbræch, Eyvind Gjønnæss, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 16, 2012
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rateSatish Arora, Einar Gude, Vilborg Sigurdardottir, et al.
Transplantation|October 30, 2010
Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trialLars Gullestad, Svend-Aage Mortensen, Hans Eiskjær, et al.
Psychosomatic Medicine|April 30, 2019
The Predictive Value of Depression in the Years After Heart Transplantation for Mortality During Long-Term Follow-UpBritta S Bürker, Lars Gullestad, Einar Gude, et al.
Clinical Transplantation|October 22, 2017
Cognitive function among long-term survivors of heart transplantationBritta S Bürker, Einar Gude, Lars Gullestad, et al.
International Journal of Molecular Sciences|May 27, 2026
Implantation of a Continuous-Flow Left Ventricular Assist Device During Cardiopulmonary Bypass Is Associated with a Significant and Transient Acute Thromboinflammatory ResponseAlexandra Gerogianni, Gro Sørensen, Tom Nilsen Hoel, et al.
Circulation|February 19, 2019
Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in ScandinaviaKari Nytrøen, Katrine Rolid, Arne Kristian Andreassen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 15, 2019
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejectionMarius Trøseid, Cristiane C K Mayerhofer, Kaspar Broch, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Health and Quality of Life Outcomes|August 19, 2020
High-intensity interval training and health-related quality of life in de novo heart transplant recipients - results from a randomized controlled trialKatrine Rolid, Arne K Andreassen, Marianne Yardley, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 13, 2016
Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trialLars Gullestad, Hans Eiskjaer, Finn Gustafsson, et al.
Heart (British Cardiac Society)|October 28, 2024
Right ventricular remodelling and long-term survival after pulmonary endarterectomy versus balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertensionHåvard Ravnestad, Klaus Murbræch, Eyvind Gjønnæss, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 16, 2012
Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rateSatish Arora, Einar Gude, Vilborg Sigurdardottir, et al.
Transplantation|October 30, 2010
Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trialLars Gullestad, Svend-Aage Mortensen, Hans Eiskjær, et al.
Psychosomatic Medicine|April 30, 2019
The Predictive Value of Depression in the Years After Heart Transplantation for Mortality During Long-Term Follow-UpBritta S Bürker, Lars Gullestad, Einar Gude, et al.
Clinical Transplantation|October 22, 2017
Cognitive function among long-term survivors of heart transplantationBritta S Bürker, Einar Gude, Lars Gullestad, et al.
International Journal of Molecular Sciences|May 27, 2026
Implantation of a Continuous-Flow Left Ventricular Assist Device During Cardiopulmonary Bypass Is Associated with a Significant and Transient Acute Thromboinflammatory ResponseAlexandra Gerogianni, Gro Sørensen, Tom Nilsen Hoel, et al.
Circulation|February 19, 2019
Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in ScandinaviaKari Nytrøen, Katrine Rolid, Arne Kristian Andreassen, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 15, 2019
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejectionMarius Trøseid, Cristiane C K Mayerhofer, Kaspar Broch, et al.
Pageof 10